DOMINION DIAGNOSTICS, LLC
NORTH KINGSTON, RI

Welcome to our company website! About Dominion Diagnostics Dominion Diagnostics provides clinical drug monitoring solutions, actionable clinical information and innovative support services to a variety of medical specialties. At Dominion Diagnostics, we’re committed to ongoing research, discovery and development of diagnostic solutions that advance patient care and improve treatment outcomes. Dominion Diagnostics was founded in 1997 by a group of scientists with a special interest in Addiction Medicine. The founders recognized clinical quantitative urine drug testing as one of the most objective diagnostic tools in patient treatment. Over time, they assembled a body of professionals that embraced the opportunity to help healthcare providers deliver a higher standard of medical care. Why choose Dominion Diagnostics? At Dominion Diagnostics, we help healthcare providers make better informed treatment decisions and improve patient outcomes through responsible, medically necessary monitoring programs. We are trusted by customers across the United States because we understand unique patient needs, support practice regulatory compliance, and are committed to improving healthcare through actionable clinical information. Protocol support to help ensure comprehensive regulatory compliance, including FDA Opioid REMS National and regional in-network provider status for greater than 80% of commercial lives served Robert M. Garvey, Jr. joined Dominion Diagnostics in 2011 and serves as its Chief Executive Officer. He also serves as Chairman of the Coalition for Excellence in Medication Monitoring (CEMM) - a coalition dedicated to advancing standards... Mark A. McSally, Esq. joined Dominion Diagnostics in 1999 as Outside General Counsel and moved internally in 2006 to assume the role of Corporate Counsel. He currently serves as Dominion’s Chief Operating Officer and General Counsel. Mr.... Arthur Brookfield joined the Dominion Diagnostics team in 2013. Mr. Brookfield has over 12 years of experience in financial leadership roles in healthcare, including eight years in diagnostic testing services. As Dominion's Chief... Kenneth F. Indof joined Dominion Diagnostics in 2011 as the Vice President of Sales and Marketing. Mr. Indof has over 20 years of executive level experience for national diagnostic leaders including Proven Diagnostics/Geisinger Health... Mary P. Hauser joined Dominion Diagnostics in 1999 and serves as Vice President of Addiction Services and New Market Development. Ms. Hauser has over four decades of experience in addiction medicine, behavioral health, mental health, and... Dr. Charlene Johnson first joined Dominion Diagnostics in 2003 as the Director of Molecular Testing. In 2009, she became the Assistant Laboratory Director for Dominion’s Rhode Island and Vermont laboratories. Dr. Johnson assumed the role... David J. Molusis joined Dominion Diagnostics in 2015 as Vice President of Information Technology. Mr. Molusis has over 20 years of experience as an accomplished healthcare IT leader and administrator. Prior to Dominion Diagnostics, Mr.... Sheri Machado joined Dominion Diagnostics in 2012 and serves as the company’s Director of Human Resources. Mrs. Machado is a seasoned professional with over 20 years of demonstrated expertise in providing innovative human resources... Dominion Diagnostics is a well-respected, trusted healthcare company with a demonstrated commitment to Dominion Diagnostics has a long history of servicing customers from a diversity of Official quick-reference tools that provide instant access to the American Society of Addiction Medicine (ASAM) The American Society of Addiction Medicine (ASAM) developed the National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use to provide information on evidence-based treatment of opioid use disorder.